The Ultimate Guide To SRO List - FDA

We make no service warranties about accuracy of industrial category. Update himalaya medicine for rheumatoid arthritis are adding and upgrading information about numerous thousands of companies every day, and regularly include companies to the queue for being upgraded. You can request a business to be contributed to the front of the queue for updating, particularly useful if the address, directors, or other critical info has actually altered.

News release content from ACCESSWIRE. The AP news personnel was not associated with its creation. DALLAS, TX/ ACCESSWIRE/ February 6, 2020/ Enzolytics- (OTC Pink Sheet-ENZC) was informed by FINRA that an unauthorized news release titled, "Enzolytics Inc., Launches Coronavirus Avoidance Kit" was dispersed to the general public. Enzolytics and its management had no understanding of this press release in any way, and disavows any info contained in this news release.

Enzolytics, Inc., Inc. is vigilantly working to bring its filings current and continue with its efforts for the commercialization of its proprietary proteins for the treatment of HIV.Enzolytics flagship substance ITV-1 (Immune Healing Vaccine-1) is a suspension of Suspended Pepsin Fraction (IPF), which research studies have actually revealed is reliable in the treatment of HIV/AIDS.

ITV-1 has been shown to modulate the immune system. ITV-1 has also been shown to have anti-viral effectiveness. Enzolytics continues to deal with its Bulgarian partner, Immunotech Laboratories, BG, to complete the recognition of the production process to send the last documents to the Bulgarian drug agency in order to obtain registration.

is a drug development company devoted to the commercialization of its proprietary proteins for the treatment of HIV/AIDS. Enzolytics is dedicated to creating drugs for the much better health of humanity, Safe Harbor Statement: This news release consists of forward-looking statements that involve dangers and uncertainties connected with monetary forecasts, spending plans, turning point timelines, scientific development, regulatory approvals, and other risks explained by Enzolytics, Inc.